An Augmented Reality Based System for Neglect Detection, Assessment, and Rehabilitation
Launched by UNIVERSITY OF PITTSBURGH · Dec 2, 2019
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new tool that uses Augmented Reality (AR) and a brain activity measurement technique called electroencephalography (EEG) to help detect and treat a condition known as neglect in individuals who have had a stroke. Neglect can make it difficult for someone to pay attention to one side of their body or their surroundings, and this trial aims to see if this new technology is both feasible and acceptable for patients in rehabilitation.
To participate in this trial, individuals must be 18 years or older, have had an acute stroke, and be currently in inpatient rehabilitation. They should also show signs of neglect based on specific tests. Participants will be expected to engage with the AR tool during their rehabilitation process. It's important to note that those with certain conditions like dementia or Parkinson's disease, or who have metal in their heads that could interfere with the EEG, will not be eligible to join. Overall, the trial seeks to understand how well this innovative approach can help improve recovery for stroke patients dealing with neglect.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • ages18 and older
- • acute stroke
- • admitted to inpatient rehabilitation
- • presence of neglect (Behavioral Inattention Test total score \<129, or scoring below pre-defined cutoff score in at least one of the six subtests)
- • more than 10/% missed targets on the Augmented Reality Screening Test
- • intact vibration (positive test on Vibration Sensation Test)
- • intact auditory function (positive test on Auditory Sensation Test)
- • English speaking
- Exclusion Criteria:
- • inability to follow one-step directions at least 80% of the time
- • current diagnosis of dementia, Parkinson's disease, multiple sclerosis, or space-occupying tumor
- • metal in the head that causes interference with the EEG system
- • self-report of previous positive photic stimulation test
About University Of Pittsburgh
The University of Pittsburgh is a leading research institution known for its commitment to advancing medical science and improving patient care through innovative clinical trials. With a robust infrastructure for research and a multidisciplinary approach, the university fosters collaboration among experts in various fields, facilitating the development of novel therapies and interventions. Its clinical trial programs emphasize ethical standards, patient safety, and the integration of cutting-edge technology, making the University of Pittsburgh a pivotal contributor to the landscape of clinical research and a trusted partner in the pursuit of health advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Pittsburgh, Pennsylvania, United States
Boston, Massachusetts, United States
Patients applied
Trial Officials
Murat Akcakaya, PhD
Principal Investigator
University of Pittsburgh
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials